Your Article Summary
See Latest ArticlesAddressing steroid phobia: Improving the risk-benefit ratio with new agents
Allergy and Asthma Proceedings, 08/28/08
Skoner JD et al. - Although some of the studies were flawed, featured drugs that are less commonly prescribed today, or both, adverse effects from chronic ICSs use are still a cause of concern today. Current therapies are designed to be efficacious at minimal doses, limiting potential side effects, increasing adherence, and improving asthma control.
Related Articles
Pharmacology of steroids used during epidural steroid injections
Techniques in Regional Anesthesia and Pain Management, 11/20/09
Relevance Score: 91%
The mechanism of action and side effects of epidural steroids
Techniques in Regional Anesthesia and Pain Management, 11/20/09
Relevance Score: 90%
Ultrasound guidance for epidural steroid injections
Techniques in Regional Anesthesia and Pain Management, 11/20/09
Relevance Score: 90%
Epidural steroid injections: An update on mechanisms of injury and safety
Techniques in Regional Anesthesia and Pain Management, 11/23/09
Relevance Score: 89%
Steroid Therapy of Septic Shock
Critical Care Clinics, 11/06/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 12/17/09
Anti-TNF-[alpha] therapy with infliximab in spondyloarthritides
Expert Review of Clinical Immunology, 12/17/09
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/17/09